J. Hankowitz

发表

Cellular processes in atherogenesis: potential targets of Ca2+ channel blockers.

G. Schmitz, E. Kovacs, J. Hankowitz, 1991, Atherosclerosis.

Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.

J. Brachmann, M. Schindewolf, P. Dohmen, 2017, Journal of the American College of Cardiology.

Potential Biochemical Mechanisms of the Antiatherogenic Properties of Calcium Antagonists

G. Schmitz, E. Kovacs, J. Hankowitz, 1991 .

Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.

J. Brachmann, M. Schindewolf, P. Dohmen, 2014, Thrombosis research.

[Treatment and Secondary Prevention of Venous Thromboembolism - Change in Oral Anticoagulation].

H. Lipp, T. Helms, H. Riess, 2017, Deutsche medizinische Wochenschrift.

Prophylaxis, Diagnosis and Therapy of Surgery-Related Complications in Orthopedic and Trauma Surgery

I. Marzi, W. Schramm, K. Berger, 2005, European Journal of Trauma.

[The effect of Ca++ antagonists on cellular lipid metabolism].

G. Schmitz, C. Schmutte, J. Hankowitz, 1990, Arzneimittel-Forschung.

Effects of purinergic agents on human mononuclear phagocytes are differentiation dependent. Implications for atherogenesis.

K. Lackner, G. Schmitz, G. Müller, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[Treatment and Secondary Prevention of Venous Thromboembolism - Change in Oral Anticoagulation].

H. Lipp, T. Helms, T. Helms, 2017, Deutsche medizinische Wochenschrift.

Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.

J. Brachmann, M. Schindewolf, P. Dohmen, 2014, Thrombosis research.